Vaccine Development Software Shows Promise in Influenza Effort, Could Help Defeat Coronavirus

Media Type
Article
Publish or Event Date
Research Institution
Los Alamos National Laboratory
Short Title
Vaccine Development Software Shows Promise in Influenza Effort, Could Help Defeat Coronavirus
Content Coordinator
Content Manager

Deep Immune Profiling Shows Significant Immune Activation in Children with MIS-C

Media Type
Article
Publish or Event Date
Research Institution
Children’s Hospital of Philadelphia
Short Title
Deep Immune Profiling Shows Significant Immune Activation in Children with MIS-C
Content Coordinator
Content Manager

Vaccine Shows Signs of Protection Against Dozen-Plus Flu Strains

Study Reveals Details of Immune Defense Guidance System

Monoclonal Antibody “Cocktail” Blocks COVID-19 Variants—Study

New Evidence COVID-19 Antibodies, Vaccines Less Effective Against Variants

Media Type
Article
Publish or Event Date
Research Institution
Washington University School of Medicine in St. Louis
Short Title
New Evidence COVID-19 Antibodies, Vaccines Less Effective Against Variants
Content Coordinator
Content Manager

Immune Cell Implicated in Development of Lung Disease Following Viral Infection

Media Type
Article
Publish or Event Date
Research Institution
Washington University School of Medicine in St. Louis
Short Title
Immune Cell Implicated in Development of Lung Disease Following Viral Infection
Content Coordinator
Content Manager

90-Day Dapivirine Ring for Women’s HIV Prevention Passes Its First Test in Phase I Study

Media Type
Article
Publish or Event Date
Research Institution
Microbicide Trials Network
Short Title
90-Day Dapivirine Ring for Women’s HIV Prevention Passes Its First Test in Phase I Study
Content Coordinator
Content Manager

Capitalizing on Measles Vaccine’s Successful History to Protect Against SARS-CoV-2

Media Type
Article
Publish or Event Date
Research Institution
The Ohio State University Department of Veterinary Biosciences
Short Title
Capitalizing on Measles Vaccine’s Successful History to Protect Against SARS-CoV-2
Content Coordinator
Content Manager

Real World Data Reveal Risks of Allergic Reactions after Receiving COVID-19 mRNA Vaccines

Media Type
Article
Publish or Event Date
Research Institution
Massachusetts General Hospital
Short Title
Real World Data Reveal Risks of Allergic Reactions after Receiving COVID-19 mRNA Vaccines
Content Coordinator
Content Manager